2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine

C51H97N3O12 — CID 163004408

IUPAC2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine
SMILESCCCCC[C@@H]1C(=O)O[C@@H]([C@H](C)[C@H](O)CCCN=C(N)N)[C@@H](C)C=C(C)CCCC[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H](O)CC=C(C)[C@@H](O)CCC[C@H](O)CCC[C@H](O)CC[C@@H](C)[C@@H]1O
InChIInChI=1S/C51H97N3O12/c1-7-8-9-20-45-48(64)35(4)24-25-39(56)18-12-17-38(55)19-13-21-46(62)34(3)23-26-41(58)30-43(60)32-44(61)31-42(59)29-40(57)16-11-10-15-33(2)28-36(5)49(66-50(45)65)37(6)47(63)22-14-27-54-51(52)53/h23,28,35-49,55-64H,7-22,24-27,29-32H2,1-6H3,(H4,52,53,54)/t35-,36+,37-,38-,39+,40+,41+,42+,43-,44+,45+,46+,47-,48+,49-/m1/s1
InChIKeyHLOCLNAPDUAVNF-RUVOZMRISA-N
MW944.35 g/mol
LogP5.20
Rot. Bonds10

About 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine

2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine (PubChem CID 163004408) has the molecular formula C51H97N3O12 and a molecular weight of 944.35 g/mol. Its IUPAC name is 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine.

Molecular Properties

Compound Name2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine
PubChem CID163004408
Molecular FormulaC51H97N3O12
Molecular Weight944.35 g/mol
Exact Mass943.71
IUPAC Name2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine
SMILESCCCCC[C@@H]1C(=O)O[C@@H]([C@H](C)[C@H](O)CCCN=C(N)N)[C@@H](C)C=C(C)CCCC[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H](O)CC=C(C)[C@@H](O)CCC[C@H](O)CCC[C@H](O)CC[C@@H](C)[C@@H]1O
InChIInChI=1S/C51H97N3O12/c1-7-8-9-20-45-48(64)35(4)24-25-39(56)18-12-17-38(55)19-13-21-46(62)34(3)23-26-41(58)30-43(60)32-44(61)31-42(59)29-40(57)16-11-10-15-33(2)28-36(5)49(66-50(45)65)37(6)47(63)22-14-27-54-51(52)53/h23,28,35-49,55-64H,7-22,24-27,29-32H2,1-6H3,(H4,52,53,54)/t35-,36+,37-,38-,39+,40+,41+,42+,43-,44+,45+,46+,47-,48+,49-/m1/s1
InChIKeyHLOCLNAPDUAVNF-RUVOZMRISA-N
XLogP5.20
TPSA293.00 Ų
H-Bond Donors12
H-Bond Acceptors13
Rotatable Bonds10
Heavy Atoms66
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500944.35
LogP ≤ 55.20
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine?
The IUPAC name of 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine (CID 163004408) is 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine.
What is the SMILES notation for 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine?
The canonical SMILES for 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine is CCCCC[C@@H]1C(=O)O[C@@H]([C@H](C)[C@H](O)CCCN=C(N)N)[C@@H](C)C=C(C)CCCC[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H](O)CC=C(C)[C@@H](O)CCC[C@H](O)CCC[C@H](O)CC[C@@H](C)[C@@H]1O.
What is the InChIKey of 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine?
The InChIKey is HLOCLNAPDUAVNF-RUVOZMRISA-N. The full InChI is InChI=1S/C51H97N3O12/c1-7-8-9-20-45-48(64)35(4)24-25-39(56)18-12-17-38(55)19-13-21-46(62)34(3)23-26-41(58)30-43(60)32-44(61)31-42(59)29-40(57)16-11-10-15-33(2)28-36(5)49(66-50(45)65)37(6)47(63)22-14-27-54-51(52)53/h23,28,35-49,55-64H,7-22,24-27,29-32H2,1-6H3,(H4,52,53,54)/t35-,36+,37-,38-,39+,40+,41+,42+,43-,44+,45+,46+,47-,48+,49-/m1/s1.
What are the key properties of 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine?
2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine has a molecular weight of 944.35 g/mol, XLogP of 5.20, 10 rotatable bonds, 12 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(4R,5R)-4-hydroxy-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-35-pentyl-1-oxacyclohexatriaconta-4,20-dien-2-yl]hexyl]guanidine is sourced from PubChem (CID 163004408), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).